← Back to guidelines
Cardiology21 papers

Myoepithelial carcinoma

Last edited: 4/22/2026

Overview

Myoepithelial carcinoma is a rare malignant neoplasm originating from myoepithelial cells, often found in salivary glands but can occur in other locations including the mediastinum and cardiac chambers 1.

Diagnosis

  • Imaging studies (CT, MRI) essential for initial assessment and tumor localization 1.
  • Histopathological examination required for definitive diagnosis, identifying characteristic features of myoepithelial carcinoma 1.
  • Immunohistochemistry typically shows expression of both epithelial and smooth muscle markers 1.
  • Management

  • Primary Treatment: Tumor debulking surgery when feasible 1.
  • Adjuvant Therapy: Radiation therapy recommended post-surgery to target residual disease 1.
  • No specific drug dosing mentioned for systemic therapy in the provided abstract.
  • Special Populations

  • Elderly: No specific considerations noted in the provided abstract 1.
  • Comorbidities: Management may need adjustment based on patient comorbidities, though specific guidance not provided 1.
  • Key Recommendations

  • Perform comprehensive imaging (CT, MRI) for accurate localization and staging of myoepithelial carcinoma 1.
  • Confirm diagnosis through histopathological examination with immunohistochemical staining 1.
  • Consider surgical debulking for resectable tumors, followed by adjuvant radiation therapy 1 (Evidence: Weak).
  • References

    1 Briasoulis A, Salem N, Siddiqui F, Rashed A, Othman M. Myoepithelial carcinoma in the mediastinum involving the left atrium. Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology 2016. link

    Original source

    1. [1]
      Myoepithelial carcinoma in the mediastinum involving the left atrium.Briasoulis A, Salem N, Siddiqui F, Rashed A, Othman M Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology (2016)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG